Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

China flag China · Delayed Price · Currency is CNY
6.55
+0.08 (1.24%)
At close: Jan 23, 2026
-0.46%
Market Cap4.27B
Revenue (ttm)246.35M
Net Income (ttm)171.34M
Shares Out651.90M
EPS (ttm)0.27
PE Ratio24.69
Forward PEn/a
Dividend0.08 (1.21%)
Ex-Dividend DateJul 15, 2025
Volume9,510,852
Average Volume13,599,560
Open6.48
Previous Close6.47
Day's Range6.45 - 6.55
52-Week Range5.93 - 8.01
Beta0.46
RSI49.98
Earnings DateApr 30, 2026

About SHA:603718

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloprot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 366
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603718
Full Company Profile

Financial Performance

In 2024, SHA:603718's revenue was 271.04 million, an increase of 12.59% compared to the previous year's 240.72 million. Earnings were 171.18 million, an increase of 172.28%.

Financial Statements